抑制DDX3调节了在侵袭性乳腺癌中免疫信号传递的过程
Farhad Vesuna1, Paul T Winnard1, Marise Heerma van Voss1
1Division of Cancer Imaging Research, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Cancer letters
|September 28, 2025
概括
一种新的小分子抑制剂RK-33针对DDX3有效杀死三阴性乳腺癌 (TNBC) 和炎性乳腺癌 (IBC) 细胞. 这种向疗法通过减少瘤生长和激活免疫系统,显示出有希望的结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 三阴性乳腺癌 (TNBC) 和炎症性乳腺癌 (IBC) 是具有有限治疗选择的侵袭性亚型.
- 在TNBC和IBC中,治疗耐药性源于缺乏特定生物标志物和疾病异质性.
- 一种RNA螺旋酶DDX3在IBC中过度表达,因此具有潜在的治疗点.
研究的目的:
- 研究一种新型小分子抑制剂RK-33的疗效,该药物向TNBC和IBC中的DDX3.
- 评估RK-33对癌细胞活力,自我更新和瘤微环境的影响.
- 在TNBC临床前模型中评估RK-33的治疗潜力.
主要方法:
- 合成和应用RK-33,一个小分子抑制剂的DDX3.
- 使用TNBC和IBC细胞系进行体外研究,以评估细胞死亡,乳球形成和自我更新.
- 分析细胞因子表达,β-catenin局部化,生存水平和细胞分裂模式.
- 在免疫能力强的TNBC临床前模型中进行体内研究,以评估瘤糖解,生长和免疫反应.
主要成果:
- RK-33可以选择性地杀死TNBC和IBC细胞,同时保留正常的乳腺细胞.
- 用RK-33准DDX3诱导细胞死亡,减少乳球形成,并损害IBC细胞的自我更新.
- RK-33改变炎症性细胞因子表达,扣留β-catenin,降低生存率,并促进多极分裂.
- 通过RK-33治疗,瘤从高糖解质转移到低糖解质状态,减少乳酸,抑制生长,并在体内激活免疫系统.
结论:
- RK-33在向DDX3治疗TNBC和IBC方面表现出显著的有效性.
- RK-33表现出多方面的作用机制,包括直接细胞毒性和瘤微环境的调制.
- RK-33代表了对攻击性乳腺癌亚型的有前途的新型治疗候选者.
相关概念视频
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
01:15Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K